Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany

This Viewpoint compares use and costs of glucagon-like peptide 1 (GLP-1) receptor agonists for weight loss between the US and 3 other peer countries.

from JAMA Internal Medicine Online First https://ift.tt/KYo2PVn